Literature DB >> 16049513

Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphoma.

L Mussolin1, M Pillon, E S d'Amore, N Santoro, A Lombardi, F Fagioli, L Zanesco, A Rosolen.   

Abstract

Anaplastic large cell lymphoma (ALCL) harbors the reciprocal chromosomal translocation t(2;5)(p23;q35) in approximately 80% of the cases. The genes involved are nucleophosmin (NPM) and anaplastic lymphoma kinase (ALK) and the resulting chimeric NPM-ALK protein is thought to play a key role in the pathogenesis of t(2;5) positive ALCL. Few data on bone marrow (BM) involvement in ALCL have been published and they mostly rely on morphological examination of BM smears. We studied 52 ALCL for NPM-ALK expression by RT-PCR: 47/52 biopsies were positive. In 41 of the 47 cases we obtained the BM at diagnosis and investigated the prevalence of minimal BM infiltration by RT-PCR and real-time PCR. Minimal disseminated disease was positive in 25/41 patients (61%), of whom six had morphologically infiltrated BM. Survival analysis demonstrated a 5-year progression-free survival of 41 +/- 11% for patients with molecularly positive BM vs 100% for patients with negative BM (P = 0.001). These results suggest that minimal BM involvement at diagnosis is a common event in pediatric ALCL and that minimal BM disease monitoring could identify patients at risk of relapse.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16049513     DOI: 10.1038/sj.leu.2403888

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  20 in total

1.  Revised International Pediatric Non-Hodgkin Lymphoma Staging System.

Authors:  Angelo Rosolen; Sherrie L Perkins; C Ross Pinkerton; R Paul Guillerman; John T Sandlund; Catherine Patte; Alfred Reiter; Mitchell S Cairo
Journal:  J Clin Oncol       Date:  2015-05-04       Impact factor: 44.544

2.  Prognostic impact of minimal disseminated disease and immune response to NPM-ALK in Japanese children with ALK-positive anaplastic large cell lymphoma.

Authors:  Yuka Iijima-Yamashita; Tetsuya Mori; Atsuko Nakazawa; Reiji Fukano; Tetsuya Takimoto; Masahito Tsurusawa; Ryoji Kobayashi; Keizo Horibe
Journal:  Int J Hematol       Date:  2017-10-13       Impact factor: 2.490

Review 3.  Molecular genetics of childhood, adolescent and young adult non-Hodgkin lymphoma.

Authors:  Rodney R Miles; Rikin K Shah; J Kimble Frazer
Journal:  Br J Haematol       Date:  2016-03-11       Impact factor: 6.998

4.  Successful allogeneic stem cell transplantation for an adult with refractory anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.

Authors:  Chao-Hsun Chen; Shan-Wen Chen; Wan-Lin Shen; Tsai-Yun Chen; Chao-Jung Tsao; Wen-Tsung Huang
Journal:  Int J Hematol       Date:  2007-02       Impact factor: 2.490

5.  Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: final results of Children's Cancer Group Study 5941.

Authors:  Eric J Lowe; Richard Sposto; Sherrie L Perkins; Thomas G Gross; Jonathan Finlay; David Zwick; Minnie Abromowitch
Journal:  Pediatr Blood Cancer       Date:  2009-03       Impact factor: 3.167

6.  Expression of CD8 is associated with non-common type morphology and outcome in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.

Authors:  Dmitriy Abramov; Ilske Oschlies; Martin Zimmermann; Dmitriy Konovalov; Christine Damm-Welk; Wilhelm Wössmann; Wolfram Klapper
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

Review 7.  Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead.

Authors:  Véronique Minard-Colin; Laurence Brugières; Alfred Reiter; Mitchell S Cairo; Thomas G Gross; Wilhelm Woessmann; Birgit Burkhardt; John T Sandlund; Denise Williams; Marta Pillon; Keizo Horibe; Anne Auperin; Marie-Cécile Le Deley; Martin Zimmerman; Sherrie L Perkins; Martine Raphael; Laurence Lamant; Wolfram Klapper; Lara Mussolin; Hélène A Poirel; Elizabeth Macintyre; Christine Damm-Welk; Angelo Rosolen; Catherine Patte
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

8.  Minimal disseminated disease in childhood T-cell lymphoblastic lymphoma: a report from the children's oncology group.

Authors:  Elaine Coustan-Smith; John T Sandlund; Sherrie L Perkins; Helen Chen; Myron Chang; Minnie Abromowitch; Dario Campana
Journal:  J Clin Oncol       Date:  2009-06-22       Impact factor: 44.544

9.  Pathobiology of anaplastic large cell lymphoma.

Authors:  Pier Paolo Piccaluga; Anna Gazzola; Claudia Mannu; Claudio Agostinelli; Francesco Bacci; Elena Sabattini; Carlo Sagramoso; Roberto Piva; Fernando Roncolato; Giorgio Inghirami; Stefano A Pileri
Journal:  Adv Hematol       Date:  2011-02-06

10.  Plasma cell-free DNA in paediatric lymphomas.

Authors:  Lara Mussolin; Roberta Burnelli; Marta Pillon; Elisa Carraro; Piero Farruggia; Alessandra Todesco; Maurizio Mascarin; Angelo Rosolen
Journal:  J Cancer       Date:  2013-04-16       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.